UCB's Global Corporate Website
Welcome to UCB in the United States


Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results



UCB U.S. News

FINTEPLA® (fenfluramine) Results Examining its Impact in Managing Generalized Tonic-Clonic Seizures…

Read More

UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project

Read More

UCB at EULAR 2024: Advancing Science for Rheumatic Conditions with High Unmet Needs

Read More

Twitter Feed

For More Information